Michael T. Zimmermann, PhD

Publications

• Modeling post-translational modifications and cancer-associated mutations that impact the heterochromatin protein 1α-importin α heterodimers.

  (Zimmermann MT, Williams MM, Klee EW, Lomberk GA, Urrutia R.) Proteins. 2019 Nov;87(11):904-916.

• Molecular characterization of known and novel ACVR1 variants in phenotypes of aberrant ossification.

  (Gupta A, Zimmermann MT, Wang H, Broski SM, Sigafoos AN, Macklin SK, Urrutia RA, Clark KJ, Atwal PS, Pignolo RJ, Klee EW.) Am J Med Genet A. 2019 Sep;179(9):1764-1777.

• Recurrent mutations in ALK-negative anaplastic large cell lymphoma.

  (Luchtel RA, Zimmermann MT, Hu G, Dasari S, Jiang M, Oishi N, Jacobs HK, Zeng Y, Hundal T, Rech KL, Ketterling RP, Lee JH, Eckloff BW, Yan H, Gaonkar KS, Tian S, Ye Z, Kadin ME, Sidhu J, Jiang L, Voss J, Link BK, Syrbu SI, Facchetti F, Bennani NN, Slager SL, Ordog T, Kocher JP, Cerhan JR, Ansell SM, Feldman AL.) Blood. 2019 Jun 27;133(26):2776-2789.

• A case of Coffin-Siris syndrome with severe congenital heart disease and a novel variant.

  (Dsouza NR, Zimmermann MT, Geddes GC.) Cold Spring Harb Mol Case Stud. 2019 Jun;5(3).

• Aurora kinase B-phosphorylated HP1α functions in chromosomal instability.

  (Williams MM, Mathison AJ, Christensen T, Greipp PT, Knutson DL, Klee EW, Zimmermann MT, Iovanna J, Lomberk GA, Urrutia RA.) Cell Cycle. 2019 Jun;18(12):1407-1421.

• X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia.

  (Blackburn PR, Lin WL, Miller DA, Lorenzo-Betancor O, Edwards ES, Zimmermann MT, Farrugia LP, Freeman WD, Soto AI, Walton RL, Klee EW, Atwal PS, Abraham RS, Billadeau DD, Ross OA, Dickson DW, Meschia JF.) J Neuropathol Exp Neurol. 2019 May 01;78(5):460-466.

• Genetic variations in human papillomavirus and cervical cancer outcomes.

  (Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, Flister MJ.) Int J Cancer. 2019 05 01;144(9):2206-2214.

• Molecular modeling of LDLR aids interpretation of genomic variants.

  (Klee EW, Zimmermann MT.) J Mol Med (Berl). 2019 Apr;97(4):533-540.

• Predict drug sensitivity of cancer cells with pathway activity inference.

  (Wang X, Sun Z, Zimmermann MT, Bugrim A, Kocher JP.) BMC Med Genomics. 2019 Jan 31;12(Suppl 1):15.

• RITAN: rapid integration of term annotation and network resources.

  (Zimmermann MT, Kabat B, Grill DE, Kennedy RB, Poland GA.) PeerJ. 2019;7:e6994.

• Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy.

  (Blessing MM, Blackburn PR, Balcom JR, Krishnan C, Harrod VL, Zimmermann MT, Barr Fritcher EG, Zysk CD, Jackson RA, Nair AA, Jenkins RB, Halling KC, Kipp BR, Ida CM.) Acta Neuropathol Commun. 2018 11 05;6(1):118.

• The Importance of Biologic Knowledge and Gene Expression Context for Genomic Data Interpretation.

  (Zimmermann MT.) Front Genet. 2018;9:670.